Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study

• Main Authors: Xu HR (Author), Sheng L (Author), Chen WL (Author), Yuan F (Author), Yang MJ (Author), Li H (Author), Li XN (Author), Choi J (Author), Zhao GY (Author), Hu TX (Author), Li YG (Author), Zhang Y (Author), Chen L (Author)
• Format: Book
• Published: Dove Medical Press, 2016-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hongrong Xu,1,* Lei Sheng,1,* Weili Chen,1 Fei Yuan,1 Mengjie Yang,1 Hui Li,1 Xuening Li,1 John Choi,2 Guiyu Zhao,2 Tianxin Hu,2 Yongguo Li,2 Yi Zhang,2 Li Chen2 1Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, 2Department of Clinical Research & Development,...